WALLBOX
1.12.2022 12:06:39 CET | Business Wire | Press release
Wallbox N.V. (NYSE: WBX), a leading provider of electric vehicle (EV) charging and energy management solutions, has today announced two strategic hirings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221201005548/en/
Myriam Lhermurier Boublil, appointed Chief Communications and Public Affairs Officer for Wallbox (Photo: Business Wire)
The company strengthens its corporate structure through the creation of a new communications and public affairs team, which will be led by Myriam Lhermurier Boublil. As Chief Communications & Public Affairs Officer, Myriam will lead a growing team, already well established in Spain and the United States. The communications and public affairs team will enhance the company's global communication as it works to facilitate the adoption of electric vehicles and change the current approach to energy management, promoting Wallbox's role as a leader in the EV sector.
The company reinforces its commercial growth potential with the hiring of Javier Riaño, who joins Wallbox as its new Chief Marketing Officer. Javier will report to Masud Rabbani, the company's Chief Business Officer, and will lead the company's corporate marketing, branding and e-commerce strategy globally, helping to strengthen the brand, which is already present in 113 countries and enjoys a leadership position in its main markets, including Europe and the United States.
Enric Asunción, CEO and co-founder of Wallbox said: “We are very pleased that Myriam and Javier have joined the Wallbox team. With the creation of the new Communications and Public Affairs department led by Myriam, we will progress our strategy of positioning Wallbox as a leader in the development of technologies for charging electric vehicles on a global scale. Myriam also brings us her extensive experience in the innovation and technology sector, which is a great asset for us as we continue our mission to be a key player driving change in the way the world uses energy”.
Masud Rabbani, Wallbox's Chief Business Officer, said: “I am delighted to welcome Javier. His extensive experience in corporate marketing, e-commerce, brand management and CRM management positions, among other responsibilities, will help us continue to position Wallbox as a benchmark brand in our main markets, increasing the acceleration of our global growth and expansion. Through his leadership, we hope to be able to creatively and strategically convey our value proposition and our goal to play a key role in the transition to sustainable mobility.”
Myriam Lhermurier Boublil, who has over 25 years of experience in communications and public affairs, led teams in Europe, the Middle East and Asia during her career at Google, where she amassed experience in various leadership positions over 14 years. She also led PayPal's international communications department for more than 3 years, before moving to Barcelona in 2021 to join Domestika as Senior Vice President of Global Communications. Myriam has a degree in International Business with a master's degree in Communications from the Sorbonne University in Paris. She speaks French, English, Spanish and Hebrew.
Javier Riaño has more than 24 years of experience in marketing management positions, mainly in the consumer goods sector. In his previous role , Riaño acted as vice president of corporate marketing for Spain and director of beauty and grooming for southern Europe at Procter & Gamble. Previously, Javier Riaño has worked in different roles within the field of marketing, brand communication and e-commerce at Procter & Gamble on an international level, in cities such as Barcelona, Madrid, Rome and Geneva. Riaño has a degree in business administration and economics from Universidad Pontificia Comillas and in Law from Universidad Nacional de Educación a Distancia (UNED). Javier speaks Spanish, French, English and Italian.
About Wallbox
Wallbox is a global technology company, dedicated to changing the way the world uses energy. Wallbox creates advanced electric vehicle charging and energy management systems that redefine the relationship between users and the network. Wallbox goes beyond charging electric vehicles to give users the power to control their consumption, save money and live more sustainably. Wallbox offers a complete portfolio of charging and energy management solutions for residential, semi-public, and public use in more than 113 countries around the world. Founded in 2015 in Barcelona, where the company’s headquarters are located, Wallbox currently has more than 1,200 employees in its offices across Europe, Asia, and America. For more information, visit www.wallbox.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221201005548/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
